On March 29, 2023, Nicole Onetto, M.D., informed Viracta Therapeutics, Inc. that she will not stand for re-election as director at the Company's 2023 annual meeting of stockholders.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.85 USD | +2.62% | -4.55% | +47.37% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.37% | 32.53M | |
+2.54% | 42.75B | |
+47.70% | 41.61B | |
+12.04% | 41.34B | |
-8.83% | 26.59B | |
+7.04% | 25.49B | |
-22.62% | 18.12B | |
+30.39% | 12.24B | |
-1.99% | 11.76B | |
+9.07% | 11B |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- Viracta Therapeutics, Inc. Announces Nicole Onetto Will Not Stand for Re-Election as Director